| Rank |
Page title |
Views |
Daily average |
Assessment |
Importance |
|---|
| 1 |
2026 Ebola epidemic |
220,945 |
7,364 |
C |
Mid |
| 2 |
Ebola |
152,714 |
5,090 |
B |
Top |
| 3 |
COVID-19 pandemic |
150,918 |
5,030 |
GA |
Top |
| 4 |
COVID-19 |
86,096 |
2,869 |
B |
Top |
| 5 |
Rabies |
85,526 |
2,850 |
B |
Top |
| 6 |
HIV/AIDS |
81,644 |
2,721 |
GA |
Top |
| 7 |
Hantavirus |
75,099 |
2,503 |
B |
Top |
| 8 |
Smallpox |
65,321 |
2,177 |
GA |
Top |
| 9 |
Creutzfeldt–Jakob disease |
59,147 |
1,971 |
B |
Top |
| 10 |
Mosquito |
57,126 |
1,904 |
GA |
Mid |
| 11 |
Spanish flu |
53,620 |
1,787 |
GA |
Top |
| 12 |
List of epidemics and pandemics |
52,182 |
1,739 |
List |
High |
| 13 |
Prion |
51,079 |
1,702 |
GA |
Top |
| 14 |
MV Hondius hantavirus outbreak |
45,481 |
1,516 |
C |
Low |
| 15 |
Human papillomavirus infection |
44,433 |
1,481 |
B |
Top |
| 16 |
Shingles |
43,355 |
1,445 |
GA |
Top |
| 17 |
Foot-and-mouth disease |
43,153 |
1,438 |
B |
High |
| 18 |
Polio |
41,341 |
1,378 |
B |
Top |
| 19 |
HIV |
40,294 |
1,343 |
GA |
Top |
| 20 |
Virus |
39,516 |
1,317 |
FA |
Top |
| 21 |
Chickenpox |
39,266 |
1,308 |
B |
Top |
| 22 |
Epstein–Barr virus |
37,620 |
1,254 |
B |
Top |
| 23 |
Hodgkin lymphoma |
36,312 |
1,210 |
B |
Top |
| 24 |
Infectious mononucleosis |
35,076 |
1,169 |
B |
Top |
| 25 |
Hand, foot, and mouth disease |
33,993 |
1,133 |
B |
High |
| 26 |
Norovirus |
33,392 |
1,113 |
B |
Top |
| 27 |
Western African Ebola epidemic |
33,337 |
1,111 |
GA |
Mid |
| 28 |
Bell's palsy |
31,905 |
1,063 |
B |
Top |
| 29 |
Measles |
31,512 |
1,050 |
B |
Top |
| 30 |
COVID-19 pandemic in the United States |
28,997 |
966 |
B |
Low |
| 31 |
HeLa |
28,218 |
940 |
C |
Mid |
| 32 |
Rosalind Franklin |
27,978 |
932 |
B |
High |
| 33 |
Dengue fever |
27,511 |
917 |
FA |
Top |
| 34 |
Kaposi's sarcoma |
26,272 |
875 |
C |
Mid |
| 35 |
Bundibugyo ebolavirus |
26,041 |
868 |
Start |
Low |
| 36 |
Chronic wasting disease |
25,856 |
861 |
B |
Top |
| 37 |
Orf (disease) |
25,272 |
842 |
Start |
Low |
| 38 |
Variant Creutzfeldt–Jakob disease |
23,796 |
793 |
B |
High |
| 39 |
Yellow fever |
23,778 |
792 |
B |
Top |
| 40 |
Influenza |
23,735 |
791 |
FA |
Top |
| 41 |
Herpes |
23,708 |
790 |
GA |
Top |
| 42 |
History of HIV/AIDS |
23,165 |
772 |
B |
Top |
| 43 |
Molluscum contagiosum |
22,704 |
756 |
B |
High |
| 44 |
SARS-CoV-2 |
22,165 |
738 |
B |
Top |
| 45 |
List of Ebola outbreaks |
21,816 |
727 |
List |
Low |
| 46 |
COVID-19 pandemic by country and territory |
19,839 |
661 |
List |
Top |
| 47 |
Gastroenteritis |
18,637 |
621 |
GA |
Top |
| 48 |
West Nile virus |
17,928 |
597 |
B |
High |
| 49 |
COVID-19 pandemic deaths |
17,035 |
567 |
C |
Low |
| 50 |
Bacteriophage |
16,783 |
559 |
B |
Top |
| 51 |
Respiratory syncytial virus |
16,402 |
546 |
B |
High |
| 52 |
Epidemiology of HIV/AIDS |
15,955 |
531 |
C |
High |
| 53 |
Rhinovirus |
15,939 |
531 |
C |
High |
| 54 |
1889–1890 pandemic |
15,840 |
528 |
C |
Mid |
| 55 |
Hepatitis C |
15,453 |
515 |
C |
Top |
| 56 |
Hantavirus pulmonary syndrome |
15,401 |
513 |
B |
High |
| 57 |
HIV/AIDS in the United States |
14,835 |
494 |
C |
Low |
| 58 |
Powassan virus |
14,730 |
491 |
C |
Mid |
| 59 |
Coronavirus |
14,668 |
488 |
C |
High |
| 60 |
Shope papilloma virus |
14,657 |
488 |
C |
Mid |
| 61 |
COVID-19 lab leak theory |
14,414 |
480 |
B |
Low |
| 62 |
Edward Jenner |
13,716 |
457 |
B |
High |
| 63 |
Mumps |
13,532 |
451 |
B |
Top |
| 64 |
Common cold |
13,503 |
450 |
C |
Top |
| 65 |
Ebolavirus |
13,218 |
440 |
C |
Mid |
| 66 |
Hepatitis B |
13,174 |
439 |
GA |
Top |
| 67 |
Canine parvovirus |
13,090 |
436 |
B |
Top |
| 68 |
Smallpox vaccine |
12,655 |
421 |
B |
Mid |
| 69 |
Herpes simplex virus |
12,381 |
412 |
B |
Top |
| 70 |
2009 swine flu pandemic |
12,308 |
410 |
GA |
High |
| 71 |
Rubella |
12,096 |
403 |
B |
Top |
| 72 |
SARS |
11,961 |
398 |
C |
Top |
| 73 |
Genital wart |
11,810 |
393 |
B |
Top |
| 74 |
Zaire ebolavirus |
11,795 |
393 |
C |
Top |
| 75 |
Pandemic |
11,791 |
393 |
B |
High |
| 76 |
COVID-19 pandemic in India |
11,768 |
392 |
B |
High |
| 77 |
COVID-19 vaccine |
11,665 |
388 |
B |
Top |
| 78 |
Cytomegalovirus |
11,643 |
388 |
B |
Top |
| 79 |
Marburg virus |
11,384 |
379 |
C |
High |
| 80 |
Vaccine |
11,366 |
378 |
B |
Top |
| 81 |
Chikungunya |
11,321 |
377 |
B |
High |
| 82 |
Cervical cancer |
11,014 |
367 |
B |
High |
| 83 |
Viral hemorrhagic fever |
10,880 |
362 |
C |
High |
| 84 |
2002–2004 SARS outbreak |
10,589 |
352 |
B |
Mid |
| 85 |
Tick-borne encephalitis |
10,473 |
349 |
Start |
Low |
| 86 |
Amantadine |
10,462 |
348 |
C |
High |
| 87 |
Origin of SARS-CoV-2 |
10,308 |
343 |
B |
Mid |
| 88 |
Croup |
10,282 |
342 |
GA |
Top |
| 89 |
COVID-19 misinformation |
10,156 |
338 |
B |
Low |
| 90 |
HPV vaccine |
10,093 |
336 |
B |
High |
| 91 |
Index case |
9,857 |
328 |
Start |
Low |
| 92 |
Rotavirus |
9,759 |
325 |
FA |
Top |
| 93 |
Canine distemper |
9,603 |
320 |
B |
Top |
| 94 |
Zidovudine |
9,514 |
317 |
B |
High |
| 95 |
Cold sore |
9,240 |
308 |
C |
Top |
| 96 |
Gain-of-function research |
9,139 |
304 |
C |
High |
| 97 |
Varicella zoster virus |
9,120 |
304 |
C |
High |
| 98 |
Hantavirus infection |
8,813 |
293 |
C |
Low |
| 99 |
Avian influenza |
8,743 |
291 |
B |
High |
| 100 |
Ebola virus cases in the United States |
8,717 |
290 |
C |
High |
| 101 |
List of deaths due to the COVID-19 pandemic |
8,703 |
290 |
List |
High |
| 102 |
Influenza A virus subtype H1N1 |
8,586 |
286 |
C |
Top |
| 103 |
Retrovirus |
8,532 |
284 |
C |
Top |
| 104 |
COVID-19 pandemic in the United Kingdom |
8,487 |
282 |
C |
Low |
| 105 |
Mpox |
8,433 |
281 |
C |
High |
| 106 |
Myxomatosis |
8,103 |
270 |
GA |
High |
| 107 |
Genital herpes |
8,063 |
268 |
C |
High |
| 108 |
Influenza A virus subtype H5N1 |
8,062 |
268 |
B |
Top |
| 109 |
Alphapithovirus |
8,003 |
266 |
C |
High |
| 110 |
Timeline of the COVID-19 pandemic |
7,810 |
260 |
List |
Top |
| 111 |
Nipah virus |
7,805 |
260 |
C |
Mid |
| 112 |
Rinderpest |
7,692 |
256 |
B |
High |
| 113 |
Incertae sedis |
7,683 |
256 |
C |
Low |
| 114 |
Timeline of HIV/AIDS |
7,618 |
253 |
List |
Mid |
| 115 |
Lyssavirus |
7,267 |
242 |
C |
Mid |
| 116 |
Hepatitis A |
7,262 |
242 |
C |
Top |
| 117 |
Rabies virus |
6,887 |
229 |
C |
Top |
| 118 |
Sore throat |
6,748 |
224 |
C |
High |
| 119 |
Varicella vaccine |
6,728 |
224 |
B |
Top |
| 120 |
Influenza A virus |
6,513 |
217 |
B |
Top |
| 121 |
Feline leukemia virus |
6,440 |
214 |
C |
High |
| 122 |
Marburg virus disease |
6,418 |
213 |
C |
High |
| 123 |
Coxsackievirus |
6,417 |
213 |
C |
High |
| 124 |
Remdesivir |
6,404 |
213 |
C |
High |
| 125 |
COVID-19 pandemic in Australia |
6,283 |
209 |
B |
Low |
| 126 |
Herpesviridae |
6,262 |
208 |
C |
Top |
| 127 |
Andes virus |
6,205 |
206 |
B |
Mid |
| 128 |
Zika virus |
6,142 |
204 |
B |
Top |
| 129 |
Operation Warp Speed |
6,138 |
204 |
C |
High |
| 130 |
Anti-vaccine activism |
6,084 |
202 |
B |
Low |
| 131 |
Messenger RNA |
6,081 |
202 |
C |
High |
| 132 |
2001 United Kingdom foot-and-mouth outbreak |
5,959 |
198 |
C |
Mid |
| 133 |
Interferon |
5,893 |
196 |
B |
Top |
| 134 |
Bioterrorism |
5,872 |
195 |
B |
Low |
| 135 |
Ebola vaccine |
5,834 |
194 |
C |
Mid |
| 136 |
Moderna |
5,760 |
192 |
C |
Low |
| 137 |
Rabies in animals |
5,731 |
191 |
C |
High |
| 138 |
Gardasil |
5,656 |
188 |
B |
High |
| 139 |
SARS-CoV-2 Omicron variant |
5,626 |
187 |
C |
High |
| 140 |
West Nile fever |
5,578 |
185 |
C |
High |
| 141 |
Enterovirus |
5,534 |
184 |
C |
High |
| 142 |
Feline immunodeficiency virus |
5,471 |
182 |
C |
High |
| 143 |
Crimean–Congo hemorrhagic fever |
5,432 |
181 |
C |
High |
| 144 |
Hong Kong flu |
5,380 |
179 |
C |
Low |
| 145 |
List of COVID-19 vaccine authorizations |
5,322 |
177 |
List |
Mid |
| 146 |
Japanese encephalitis |
5,298 |
176 |
C |
High |
| 147 |
Hantavirus hemorrhagic fever with renal syndrome |
5,188 |
172 |
B |
High |
| 148 |
1976 Zaire Ebola virus outbreak |
5,158 |
171 |
C |
Low |
| 149 |
Wuhan Institute of Virology |
5,123 |
170 |
C |
Mid |
| 150 |
Vaccination |
5,008 |
166 |
B |
Top |
| 151 |
SARS-CoV-1 |
4,957 |
165 |
C |
High |
| 152 |
Rhinorrhea |
4,937 |
164 |
C |
High |
| 153 |
Reston virus |
4,801 |
160 |
C |
Low |
| 154 |
Bundibugyo virus |
4,775 |
159 |
Redirect |
Low |
| 155 |
Filoviridae |
4,737 |
157 |
Start |
High |
| 156 |
Henipavirus |
4,715 |
157 |
C |
High |
| 157 |
Swine influenza |
4,690 |
156 |
B |
High |
| 158 |
Lassa fever |
4,668 |
155 |
B |
High |
| 159 |
Virology |
4,619 |
153 |
B |
Top |
| 160 |
Sin Nombre virus |
4,583 |
152 |
B |
High |
| 161 |
Antiviral drug |
4,532 |
151 |
B |
Top |
| 162 |
Virus classification |
4,513 |
150 |
C |
Top |
| 163 |
Pithovirus |
4,513 |
150 |
Redirect |
NA |
| 164 |
Tobacco mosaic virus |
4,477 |
149 |
C |
High |
| 165 |
Subacute sclerosing panencephalitis |
4,455 |
148 |
C |
Mid |
| 166 |
Merkel-cell carcinoma |
4,421 |
147 |
C |
Mid |
| 167 |
Lady Mary Wortley Montagu |
4,414 |
147 |
B |
Low |
| 168 |
Walter Reed |
4,397 |
146 |
Start |
Low |
| 169 |
Giant virus |
4,353 |
145 |
C |
High |
| 170 |
1978 smallpox outbreak in the United Kingdom |
4,342 |
144 |
B |
Low |
| 171 |
Variolation |
4,317 |
143 |
C |
High |
| 172 |
Subtypes of HIV |
4,281 |
142 |
C |
High |
| 173 |
Variants of SARS-CoV-2 |
4,233 |
141 |
C |
Mid |
| 174 |
Spillover infection |
4,178 |
139 |
Start |
Mid |
| 175 |
COVID-19 pandemic in New Zealand |
4,176 |
139 |
C |
Low |
| 176 |
Human metapneumovirus |
4,154 |
138 |
C |
High |
| 177 |
Vaccine hesitancy |
4,136 |
137 |
B |
High |
| 178 |
Roseola |
4,057 |
135 |
C |
High |
| 179 |
Viral disease |
4,036 |
134 |
List |
Top |
| 180 |
Poliovirus |
3,931 |
131 |
GA |
High |
| 181 |
2023–2026 mpox epidemic |
3,899 |
129 |
C |
Mid |
| 182 |
Polio eradication |
3,814 |
127 |
B |
Mid |
| 183 |
Kivu Ebola epidemic |
3,808 |
126 |
GA |
High |
| 184 |
Viroid |
3,794 |
126 |
C |
High |
| 185 |
COVID-19 testing |
3,787 |
126 |
B |
Low |
| 186 |
Adenoviridae |
3,748 |
124 |
B |
High |
| 187 |
COVID-19 pandemic in the Philippines |
3,736 |
124 |
B |
Low |
| 188 |
Host (biology) |
3,735 |
124 |
GA |
High |
| 189 |
Feline infectious peritonitis |
3,693 |
123 |
C |
High |
| 190 |
Adeno-associated virus |
3,661 |
122 |
B |
High |
| 191 |
Cowpox |
3,639 |
121 |
C |
Mid |
| 192 |
Non-cellular life |
3,600 |
120 |
Start |
Low |
| 193 |
Pandemic H1N1/09 virus |
3,591 |
119 |
C |
Mid |
| 194 |
Eastern equine encephalitis |
3,560 |
118 |
B |
Mid |
| 195 |
Respiratory syncytial virus vaccine |
3,548 |
118 |
B |
Mid |
| 196 |
RNA virus |
3,529 |
117 |
B |
Top |
| 197 |
Obelisk (biology) |
3,508 |
116 |
Start |
High |
| 198 |
MERS |
3,443 |
114 |
B |
High |
| 199 |
SV40 |
3,322 |
110 |
C |
Mid |
| 200 |
Papillomaviridae |
3,306 |
110 |
B |
Top |
| 201 |
Simian immunodeficiency virus |
3,298 |
109 |
C |
High |
| 202 |
Human T-lymphotropic virus 1 |
3,287 |
109 |
C |
High |
| 203 |
Herpes simplex encephalitis |
3,275 |
109 |
Start |
Low |
| 204 |
Human parainfluenza viruses |
3,265 |
108 |
C |
Mid |
| 205 |
1993 Four Corners hantavirus outbreak |
3,164 |
105 |
GA |
High |
| 206 |
COVID-19 pandemic in Italy |
3,146 |
104 |
B |
Mid |
| 207 |
Hepatitis D |
3,133 |
104 |
C |
Mid |
| 208 |
Severe acute respiratory syndrome coronavirus 2 |
3,130 |
104 |
Redirect |
NA |
| 209 |
Dengue virus |
3,089 |
102 |
B |
Top |
| 210 |
COVID-19 pandemic in mainland China |
3,078 |
102 |
C |
High |
| 211 |
Natural reservoir |
3,075 |
102 |
C |
High |
| 212 |
COVID-19 pandemic in Canada |
3,046 |
101 |
B |
Mid |
| 213 |
2020–2026 H5N1 outbreak |
3,027 |
100 |
C |
Low |
| 214 |
RNA interference |
3,011 |
100 |
FA |
High |
| 215 |
Baltimore classification |
2,959 |
98 |
GA |
Top |
| 216 |
Feline calicivirus |
2,954 |
98 |
C |
Top |
| 217 |
Oncovirus |
2,946 |
98 |
C |
Top |
| 218 |
COVID-19 pandemic in Victoria |
2,943 |
98 |
C |
Low |
| 219 |
Influenza vaccine |
2,911 |
97 |
B |
Top |
| 220 |
African swine fever virus |
2,908 |
96 |
C |
High |
| 221 |
Phage therapy |
2,901 |
96 |
C |
Top |
| 222 |
COVID-19 pandemic in North Korea |
2,896 |
96 |
B |
Mid |
| 223 |
History of smallpox |
2,889 |
96 |
C |
Mid |
| 224 |
Lentivirus |
2,860 |
95 |
C |
Mid |
| 225 |
Human herpesvirus 6 |
2,830 |
94 |
C |
High |
| 226 |
Timeline of the COVID-19 pandemic in 2019 |
2,804 |
93 |
List |
High |
| 227 |
Epstein–Barr virus–associated lymphoproliferative diseases |
2,795 |
93 |
C |
Mid |
| 228 |
COVID-19 pandemic in New York City |
2,779 |
92 |
C |
Low |
| 229 |
List of biosafety level 4 organisms |
2,764 |
92 |
List |
Low |
| 230 |
Nasal congestion |
2,746 |
91 |
Start |
High |
| 231 |
Dengue vaccine |
2,727 |
90 |
C |
Low |
| 232 |
DNA polymerase |
2,710 |
90 |
C |
Top |
| 233 |
Measles virus |
2,689 |
89 |
C |
Top |
| 234 |
Hepatitis B virus |
2,677 |
89 |
B |
Top |
| 235 |
Australian bat lyssavirus |
2,676 |
89 |
C |
Low |
| 236 |
Carcinogenesis |
2,670 |
89 |
B |
Mid |
| 237 |
Reverse transcriptase |
2,655 |
88 |
B |
Top |
| 238 |
Endogenous retrovirus |
2,654 |
88 |
C |
Mid |
| 239 |
Yellow fever vaccine |
2,645 |
88 |
C |
High |
| 240 |
Hendra virus |
2,642 |
88 |
Start |
Mid |
| 241 |
Human polyomavirus 2 |
2,604 |
86 |
C |
High |
| 242 |
Deer cutaneous fibroma |
2,593 |
86 |
Start |
Low |
| 243 |
COVID-19 vaccination in the United States |
2,590 |
86 |
Start |
Low |
| 244 |
1957–1958 influenza pandemic |
2,572 |
85 |
C |
Mid |
| 245 |
Virgin cleansing myth |
2,557 |
85 |
Start |
Low |
| 246 |
2022–2023 mpox outbreak |
2,537 |
84 |
B |
Mid |
| 247 |
List of antiviral drugs |
2,531 |
84 |
List |
High |
| 248 |
Kaposi's sarcoma-associated herpesvirus |
2,518 |
83 |
C |
High |
| 249 |
COVID-19 pandemic in Singapore |
2,496 |
83 |
B |
High |
| 250 |
Hepatitis C virus |
2,481 |
82 |
C |
Top |
| 251 |
B virus |
2,462 |
82 |
C |
Mid |
| 252 |
COVID-19 pandemic in Japan |
2,462 |
82 |
C |
Low |
| 253 |
Ebola virus |
2,455 |
81 |
Redirect |
NA |
| 254 |
Influenza pandemic |
2,447 |
81 |
B |
Top |
| 255 |
Vaccinia |
2,445 |
81 |
C |
High |
| 256 |
Bluetongue disease |
2,443 |
81 |
B |
High |
| 257 |
SARS-CoV-2 Delta variant |
2,430 |
81 |
C |
Mid |
| 258 |
RNA polymerase |
2,428 |
80 |
B |
High |
| 259 |
Parvovirus B19 |
2,427 |
80 |
C |
Mid |
| 260 |
Smallpox virus retention debate |
2,411 |
80 |
Start |
Low |
| 261 |
Timeline of the COVID-19 pandemic in the United States (2020) |
2,402 |
80 |
C |
Low |
| 262 |
Capsid |
2,393 |
79 |
C |
Top |
| 263 |
Escherichia virus T4 |
2,380 |
79 |
Start |
Mid |
| 264 |
Peter Daszak |
2,339 |
77 |
Start |
Low |
| 265 |
Bat virome |
2,328 |
77 |
GA |
High |
| 266 |
Marburgvirus |
2,325 |
77 |
C |
High |
| 267 |
Viral hepatitis |
2,316 |
77 |
C |
High |
| 268 |
Viral evolution |
2,296 |
76 |
C |
High |
| 269 |
1793 Philadelphia yellow fever epidemic |
2,289 |
76 |
C |
Low |
| 270 |
Sapovirus |
2,271 |
75 |
C |
High |
| 271 |
Hepatitis E |
2,265 |
75 |
GA |
High |
| 272 |
Measles vaccine |
2,265 |
75 |
C |
Low |
| 273 |
Nipah virus outbreaks in Kerala |
2,253 |
75 |
C |
Low |
| 274 |
Rift Valley fever |
2,251 |
75 |
C |
High |
| 275 |
Orthoflavivirus |
2,247 |
74 |
B |
High |
| 276 |
Riboviria |
2,230 |
74 |
B |
Top |
| 277 |
Adenovirus infection |
2,226 |
74 |
C |
Mid |
| 278 |
Rhabdoviridae |
2,216 |
73 |
C |
High |
| 279 |
COVID-19 pandemic on Diamond Princess |
2,210 |
73 |
C |
Low |
| 280 |
Anthony Epstein |
2,199 |
73 |
Start |
Mid |
| 281 |
Poxviridae |
2,197 |
73 |
C |
High |
| 282 |
Virulence |
2,194 |
73 |
C |
High |
| 283 |
Zika fever |
2,176 |
72 |
B |
High |
| 284 |
Attenuated vaccine |
2,173 |
72 |
C |
High |
| 285 |
COVID-19 pandemic in Europe |
2,154 |
71 |
C |
Low |
| 286 |
DNA virus |
2,151 |
71 |
C |
Top |
| 287 |
Mimivirus |
2,142 |
71 |
C |
Mid |
| 288 |
Human cytomegalovirus |
2,136 |
71 |
C |
High |
| 289 |
1977 Russian flu |
2,117 |
70 |
C |
Mid |
| 290 |
Monkeypox virus |
2,110 |
70 |
C |
Mid |
| 291 |
Orthopoxvirus |
2,106 |
70 |
C |
High |
| 292 |
Hershey–Chase experiment |
2,098 |
69 |
C |
Mid |
| 293 |
Rabbit hemorrhagic disease |
2,087 |
69 |
B |
Mid |
| 294 |
Sense (molecular biology) |
2,079 |
69 |
C |
High |
| 295 |
Lassa virus |
2,078 |
69 |
C |
Mid |
| 296 |
Arbovirus |
2,073 |
69 |
C |
Top |
| 297 |
HIV trial in Libya |
2,068 |
68 |
B |
Low |
| 298 |
BK virus |
2,055 |
68 |
B |
Low |
| 299 |
Discrimination against people with HIV/AIDS |
2,055 |
68 |
C |
High |
| 300 |
Ivermectin during the COVID-19 pandemic |
2,055 |
68 |
B |
Low |
| 301 |
Parvoviridae |
2,049 |
68 |
B |
Mid |
| 302 |
Virion |
2,043 |
68 |
Start |
Top |
| 303 |
Metagenomics |
2,026 |
67 |
GA |
High |
| 304 |
COVID-19 vaccine misinformation and hesitancy |
2,019 |
67 |
B |
Top |
| 305 |
SARS-related coronavirus |
2,010 |
67 |
C |
High |
| 306 |
Negative-strand RNA virus |
1,959 |
65 |
B |
Mid |
| 307 |
Viral encephalitis |
1,943 |
64 |
B |
High |
| 308 |
Timeline of human vaccines |
1,940 |
64 |
List |
Low |
| 309 |
Jonathan Van-Tam |
1,940 |
64 |
C |
Low |
| 310 |
Nipah virus infection |
1,933 |
64 |
B |
High |
| 311 |
COVID-19 pandemic in California |
1,907 |
63 |
C |
Mid |
| 312 |
Influenza B virus |
1,901 |
63 |
C |
High |
| 313 |
Coalition for Epidemic Preparedness Innovations |
1,900 |
63 |
GA |
Low |
| 314 |
Oncolytic virus |
1,889 |
62 |
B |
Mid |
| 315 |
Orthomyxoviridae |
1,865 |
62 |
B |
High |
| 316 |
List of unproven methods against COVID-19 |
1,858 |
61 |
List |
Mid |
| 317 |
Superinfection |
1,857 |
61 |
Stub |
Mid |
| 318 |
COVID-19 pandemic in Hubei |
1,855 |
61 |
C |
Mid |
| 319 |
Flat wart |
1,852 |
61 |
Stub |
Mid |
| 320 |
History of COVID-19 vaccine development |
1,852 |
61 |
C |
Low |
| 321 |
Picornavirus |
1,851 |
61 |
B |
Mid |
| 322 |
Malaysian movement control order |
1,834 |
61 |
B |
Low |
| 323 |
Lambda phage |
1,814 |
60 |
B |
High |
| 324 |
Pseudorabies |
1,803 |
60 |
C |
High |
| 325 |
Disease X |
1,794 |
59 |
GA |
Low |
| 326 |
Sea star wasting disease |
1,786 |
59 |
C |
Mid |
| 327 |
Sudan ebolavirus |
1,784 |
59 |
Start |
Low |
| 328 |
Carnivore protoparvovirus 1 |
1,781 |
59 |
Start |
Mid |
| 329 |
Viral envelope |
1,763 |
58 |
Start |
Top |
| 330 |
2015–16 Zika virus epidemic |
1,762 |
58 |
B |
Mid |
| 331 |
Flaviviridae |
1,755 |
58 |
Start |
High |
| 332 |
COVID-19 pandemic on cruise ships |
1,743 |
58 |
B |
High |
| 333 |
Inclusion bodies |
1,726 |
57 |
C |
High |
| 334 |
MERS-related coronavirus |
1,723 |
57 |
B |
High |
| 335 |
Ebola in the United Kingdom |
1,701 |
56 |
C |
Low |
| 336 |
HIV/AIDS in Russia |
1,684 |
56 |
Start |
Low |
| 337 |
List of diseases of the honey bee |
1,680 |
56 |
List |
High |
| 338 |
Koplik's spots |
1,674 |
55 |
C |
Mid |
| 339 |
Lysogenic cycle |
1,667 |
55 |
C |
High |
| 340 |
COVID-19 pandemic in Asia |
1,666 |
55 |
B |
Mid |
| 341 |
Deployment of COVID-19 vaccines |
1,665 |
55 |
C |
High |
| 342 |
COVID-19 pandemic in New South Wales |
1,665 |
55 |
B |
Low |
| 343 |
HIV vaccine development |
1,661 |
55 |
C |
Mid |
| 344 |
Variably protease-sensitive prionopathy |
1,661 |
55 |
Start |
Low |
| 345 |
Marek's disease |
1,657 |
55 |
C |
Mid |
| 346 |
MERS outbreak |
1,654 |
55 |
C |
Low |
| 347 |
Virulent Newcastle disease |
1,650 |
55 |
C |
High |
| 348 |
Feed a cold, starve a fever |
1,635 |
54 |
C |
Low |
| 349 |
White House Coronavirus Task Force |
1,631 |
54 |
C |
Low |
| 350 |
Coronavirus spike protein |
1,627 |
54 |
Start |
Low |
| 351 |
COVID-19 pandemic in France |
1,623 |
54 |
B |
Mid |
| 352 |
Diagnosis of HIV/AIDS |
1,617 |
53 |
B |
High |
| 353 |
History of virology |
1,613 |
53 |
B |
Top |
| 354 |
COVID-19 pandemic in the Republic of Ireland |
1,613 |
53 |
C |
Low |
| 355 |
Invertebrate iridescent virus 31 |
1,608 |
53 |
Start |
Low |
| 356 |
COVID-19 pandemic in Taiwan |
1,606 |
53 |
C |
Low |
| 357 |
Pandoravirus |
1,600 |
53 |
Start |
High |
| 358 |
DA2PPC vaccine |
1,594 |
53 |
C |
Low |
| 359 |
COVID-19 pandemic in New York (state) |
1,594 |
53 |
C |
Low |
| 360 |
COVID-19 pandemic in Sweden |
1,593 |
53 |
B |
Low |
| 361 |
COVID-19 vaccination mandates in the United States |
1,587 |
52 |
Start |
Low |
| 362 |
Vertically transmitted infection |
1,585 |
52 |
C |
High |
| 363 |
Human coronavirus OC43 |
1,570 |
52 |
C |
Mid |
| 364 |
Taï Forest ebolavirus |
1,563 |
52 |
Start |
Low |
| 365 |
Positive-strand RNA virus |
1,561 |
52 |
C |
High |
| 366 |
Megaklothovirus horridgei |
1,552 |
51 |
Stub |
Mid |
| 367 |
Echovirus |
1,549 |
51 |
List |
Mid |
| 368 |
New York COVID-19 nursing home scandal |
1,530 |
51 |
B |
Low |
| 369 |
Psittacine beak and feather disease |
1,518 |
50 |
Start |
Mid |
| 370 |
Timeline of the COVID-19 pandemic in January 2020 |
1,516 |
50 |
List |
High |
| 371 |
Measles resurgence in the United States |
1,506 |
50 |
C |
Low |
| 372 |
Strain (biology) |
1,504 |
50 |
C |
High |
| 373 |
Virophage |
1,501 |
50 |
C |
Mid |
| 374 |
Squirrelpox virus |
1,497 |
49 |
Start |
Mid |
| 375 |
Congenital rubella syndrome |
1,484 |
49 |
Start |
Mid |
| 376 |
COVID-19 pandemic in China |
1,482 |
49 |
C |
Mid |
| 377 |
Iridovirus |
1,476 |
49 |
C |
Low |
| 378 |
Lamivudine |
1,475 |
49 |
C |
Mid |
| 379 |
Paramyxoviridae |
1,469 |
48 |
C |
High |
| 380 |
COVID-19 pandemic in Hong Kong |
1,461 |
48 |
C |
Low |
| 381 |
Phage display |
1,449 |
48 |
C |
Mid |
| 382 |
Ravn virus |
1,449 |
48 |
Start |
Low |
| 383 |
Rotavirus vaccine |
1,440 |
48 |
C |
High |
| 384 |
COVID-19 pandemic in North America |
1,437 |
47 |
C |
Mid |
| 385 |
EnteroMix |
1,431 |
47 |
B |
Low |
| 386 |
Hantaan virus |
1,424 |
47 |
B |
Low |
| 387 |
COVID-19 pandemic in Germany |
1,421 |
47 |
C |
Low |
| 388 |
Flu season |
1,419 |
47 |
C |
High |
| 389 |
Emerging infectious disease |
1,419 |
47 |
C |
Low |
| 390 |
Molnupiravir |
1,406 |
46 |
C |
Mid |
| 391 |
1967 Marburg virus disease outbreak |
1,396 |
46 |
C |
Low |
| 392 |
Symptoms of COVID-19 |
1,388 |
46 |
C |
Low |
| 393 |
Transduction (genetics) |
1,387 |
46 |
C |
High |
| 394 |
Polyomaviridae |
1,382 |
46 |
C |
High |
| 395 |
Ebola virus epidemic in Guinea |
1,377 |
45 |
B |
High |
| 396 |
Spike protein |
1,372 |
45 |
Start |
Low |
| 397 |
COVID-19 pandemic in South Korea |
1,372 |
45 |
B |
Low |
| 398 |
COVID-19 pandemic in Spain |
1,369 |
45 |
C |
Low |
| 399 |
Primate T-lymphotropic virus |
1,363 |
45 |
C |
High |
| 400 |
COVID-19 vaccination in the United Kingdom |
1,360 |
45 |
C |
Low |
| 401 |
SARS-CoV-2 Alpha variant |
1,358 |
45 |
C |
Low |
| 402 |
COVID-19 pandemic in Malaysia |
1,357 |
45 |
B |
High |
| 403 |
Mumps virus |
1,350 |
45 |
B |
High |
| 404 |
Superspreading event |
1,342 |
44 |
C |
High |
| 405 |
COVID-19 pandemic in Israel |
1,340 |
44 |
C |
Mid |
| 406 |
Timeline of the COVID-19 pandemic in March 2020 |
1,332 |
44 |
List |
High |
| 407 |
Realm (virology) |
1,329 |
44 |
B |
Top |
| 408 |
Deformed wing virus |
1,325 |
44 |
C |
High |
| 409 |
Feline viral rhinotracheitis |
1,318 |
43 |
B |
Top |
| 410 |
Virus latency |
1,314 |
43 |
C |
High |
| 411 |
Intracellular parasite |
1,311 |
43 |
Start |
Mid |
| 412 |
Kyasanur Forest disease |
1,302 |
43 |
B |
Mid |
| 413 |
735–737 Japanese smallpox epidemic |
1,294 |
43 |
C |
Low |
| 414 |
Orthornavirae |
1,294 |
43 |
B |
High |
| 415 |
Lymphocytic choriomeningitis |
1,292 |
43 |
B |
Mid |
| 416 |
Virus world hypothesis |
1,284 |
42 |
B |
Mid |
| 417 |
Negri body |
1,280 |
42 |
Start |
Mid |
| 418 |
Vaccination requirements for international travel |
1,276 |
42 |
B |
Mid |
| 419 |
HPV vaccination in Japan |
1,275 |
42 |
B |
Low |
| 420 |
Shi Zhengli |
1,274 |
42 |
Start |
Low |
| 421 |
COVID-19 pandemic in Russia |
1,274 |
42 |
C |
Low |
| 422 |
Introduction to viruses |
1,272 |
42 |
FA |
Top |
| 423 |
Viral pneumonia |
1,263 |
42 |
C |
High |
| 424 |
Banana bunchy top virus |
1,263 |
42 |
C |
Mid |
| 425 |
Alphavirus |
1,258 |
41 |
C |
Mid |
| 426 |
COVID-19 pandemic in Oregon |
1,257 |
41 |
B |
Low |
| 427 |
Arenavirus |
1,254 |
41 |
C |
High |
| 428 |
Tomato yellow leaf curl virus |
1,254 |
41 |
C |
Low |
| 429 |
Vaccine misinformation |
1,243 |
41 |
C |
Mid |
| 430 |
Ebola in Nigeria |
1,239 |
41 |
C |
Low |
| 431 |
Eczema herpeticum |
1,238 |
41 |
Start |
Low |
| 432 |
GS-441524 |
1,235 |
41 |
Start |
Low |
| 433 |
BA.3.2 |
1,234 |
41 |
Start |
Low |
| 434 |
COVID-19 vaccination in India |
1,233 |
41 |
C |
Low |
| 435 |
Bolivian hemorrhagic fever |
1,232 |
41 |
Start |
Mid |
| 436 |
Innate resistance to HIV |
1,232 |
41 |
C |
High |
| 437 |
Timeline of the COVID-19 pandemic in Canada |
1,226 |
40 |
B |
Mid |
| 438 |
Feline spongiform encephalopathy |
1,225 |
40 |
C |
Low |
| 439 |
COVID-19 pandemic in Florida |
1,201 |
40 |
C |
Low |
| 440 |
Timeline of the COVID-19 pandemic in the United Kingdom (July–December 2020) |
1,194 |
39 |
List |
Low |
| 441 |
COVID-19 pandemic in Pakistan |
1,193 |
39 |
B |
Low |
| 442 |
Harald zur Hausen |
1,189 |
39 |
B |
Mid |
| 443 |
HIV superinfection |
1,180 |
39 |
C |
Mid |
| 444 |
West African Ebola virus epidemic timeline |
1,171 |
39 |
List |
Mid |
| 445 |
2019 Samoa measles outbreak |
1,171 |
39 |
C |
Low |
| 446 |
Heartland virus |
1,159 |
38 |
C |
Low |
| 447 |
Metapneumovirus |
1,154 |
38 |
Stub |
Mid |
| 448 |
Viral replication |
1,148 |
38 |
C |
Top |
| 449 |
Astrovirus |
1,148 |
38 |
B |
Low |
| 450 |
Macfarlane Burnet |
1,146 |
38 |
C |
Low |
| 451 |
Rubella virus |
1,145 |
38 |
C |
High |
| 452 |
Bunyaviricetes |
1,144 |
38 |
C |
Mid |
| 453 |
Tick-borne encephalitis virus |
1,143 |
38 |
C |
High |
| 454 |
Saint Louis encephalitis |
1,140 |
38 |
C |
Mid |
| 455 |
Caliciviridae |
1,139 |
37 |
C |
Mid |
| 456 |
Influenza A virus subtype H3N2 |
1,139 |
37 |
C |
High |
| 457 |
RNA-dependent RNA polymerase |
1,139 |
37 |
C |
Top |
| 458 |
Foot-and-mouth disease virus |
1,138 |
37 |
Start |
Mid |
| 459 |
Ian Frazer |
1,119 |
37 |
C |
Mid |
| 460 |
Cancer in cats |
1,112 |
37 |
C |
Mid |
| 461 |
Reverse-transcriptase inhibitor |
1,107 |
36 |
C |
High |
| 462 |
Viral cardiomyopathy |
1,105 |
36 |
Start |
High |
| 463 |
Viral load |
1,101 |
36 |
Start |
Mid |
| 464 |
Pigeon pox |
1,097 |
36 |
Start |
Low |
| 465 |
Neurotropic virus |
1,089 |
36 |
Start |
High |
| 466 |
Bombali ebolavirus |
1,088 |
36 |
Start |
Mid |
| 467 |
Feline coronavirus |
1,083 |
36 |
C |
Mid |
| 468 |
COVID-19 pandemic in the Netherlands |
1,083 |
36 |
C |
Low |
| 469 |
Rolling circle replication |
1,076 |
35 |
C |
Mid |
| 470 |
Puumala virus |
1,074 |
35 |
B |
Low |
| 471 |
Human virome |
1,070 |
35 |
C |
Mid |
| 472 |
White House COVID-19 outbreak |
1,070 |
35 |
C |
Low |
| 473 |
COVID-19 pandemic in South Africa |
1,067 |
35 |
B |
Mid |
| 474 |
Antibody-dependent enhancement |
1,064 |
35 |
C |
High |
| 475 |
Timeline of the COVID-19 pandemic in New York City |
1,055 |
35 |
C |
Low |
| 476 |
Duplodnaviria |
1,053 |
35 |
B |
Top |
| 477 |
Hop latent viroid |
1,050 |
35 |
Stub |
Low |
| 478 |
Phi X 174 |
1,047 |
34 |
Start |
Mid |
| 479 |
Coronaviridae |
1,046 |
34 |
Start |
High |
| 480 |
Viral phylodynamics |
1,041 |
34 |
B |
Mid |
| 481 |
Hantaviridae |
1,039 |
34 |
Stub |
Mid |
| 482 |
Lujo virus |
1,029 |
34 |
Start |
Mid |
| 483 |
MOG antibody disease |
1,028 |
34 |
C |
Mid |
| 484 |
1972 Yugoslav smallpox outbreak |
1,026 |
34 |
C |
Low |
| 485 |
Tulip breaking virus |
1,022 |
34 |
C |
Mid |
| 486 |
Novel virus |
1,022 |
34 |
Redirect |
Mid |
| 487 |
Human herpesvirus 7 |
1,018 |
33 |
C |
Mid |
| 488 |
Suniti Solomon |
1,014 |
33 |
Start |
Mid |
| 489 |
Hantavirus vaccine |
1,013 |
33 |
Start |
High |
| 490 |
Global spread of H5N1 |
1,011 |
33 |
B |
High |
| 491 |
Ebola virus epidemic in Liberia |
1,010 |
33 |
C |
Mid |
| 492 |
Coxsackie A virus |
1,009 |
33 |
Start |
Mid |
| 493 |
Venezuelan equine encephalitis virus |
1,001 |
33 |
Start |
Mid |
| 494 |
Broadway Cares/Equity Fights AIDS |
1,000 |
33 |
C |
Low |
| 495 |
2012 Yosemite hantavirus outbreak |
998 |
33 |
Start |
Low |
| 496 |
Syncytin-1 |
996 |
33 |
C |
Low |
| 497 |
Plant virus |
995 |
33 |
C |
Top |
| 498 |
COVID-19 pandemic in Indonesia |
995 |
33 |
C |
Low |
| 499 |
Hosta virus X |
994 |
33 |
Start |
Low |
| 500 |
2020–21 Singapore circuit breaker measures |
991 |
33 |
C |
Low |
|
